|
Powered by Cell Signaling Technology |
Site Information |
---|
ALGINSGysKRALML SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 10036101 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Putative in vivo kinases: | |
Kinases, in vitro: | |
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on PLD2: | |
Effects of modification on biological processes: | |
Induce interaction with: |
References | |
---|---|
Hatton N, et al. (2015) Phosphatidic Acid Increases Epidermal Growth Factor Receptor Expression by Stabilizing mRNA Decay and by Inhibiting Lysosomal and Proteasomal Degradation of the Internalized Receptor. Mol Cell Biol 35, 3131-44
26124282 Curated Info |
|
Mahankali M, Henkels KM, Gomez-Cambronero J (2013) A GEF-to-phospholipase molecular switch caused by phosphatidic acid, Rac and JAK tyrosine kinase that explains leukocyte cell migration. J Cell Sci 126, 1416-28
23378025 Curated Info |
|
Henkels KM, et al. (2011) Cell Invasion of Highly Metastatic MTLn3 Cancer Cells Is Dependent on Phospholipase D2 (PLD2) and Janus Kinase 3 (JAK3). J Mol Biol 408, 850-62
21414324 Curated Info |
|
Henkels KM, Peng HJ, Frondorf K, Gomez-Cambronero J (2010) A comprehensive model that explains the regulation of phospholipase D2 activity by phosphorylation-dephosphorylation. Mol Cell Biol 30, 2251-63
20176813 Curated Info |
|
Henkels KM, et al. (2009) PLD2 has both enzymatic and cell proliferation-inducing capabilities, that are differentially regulated by phosphorylation and dephosphorylation. Biochem Biophys Res Commun 389, 224-8
19715678 Curated Info |